insights_auto
Why is TMCI down 7,25%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,16 $
arrow_downward
-7,25%(-0,32) 1D
6 հոկ, 13:39:34 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,53 $
High
4,53 $
Low
4,09 $
Mkt. cap
264,79 մլն
Avg. vol.
235,91 հզր
Volume
151,00 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,53 $
High
4,53 $
Low
4,09 $
Mkt. cap
264,79 մլն
Avg. vol.
235,91 հզր
Volume
151,00 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
The Washington Post
·
57 րոպե առաջ
Stocks hit new record high even as consumers feel dreary
MarketForces Africa
·
29 րոպե առաջ
XRP Establishes Price Floor Ahead Of Evernorth Nasdaq Listing
Simply Wall Street
·
3 րոպե առաջ
Sovereign AI Deal Might Change The Case For Investing In Palantir (PLTR)
Reuters
·
3 ժամ առաջ
US software stocks scale fresh 2026 highs as AI disruption worries fade
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc